At a glance
- Originator Wilex
- Developer WILEX AG
- Class Antineoplastics; Aromatic amino acids; Small molecules
- Mechanism of Action Plasminogen activator inhibitor-1 inhibitors; Urokinase-type plasminogen activator inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Solid tumours